MarketBeat provided average rating data for Quince Therapeutics, Inc., following a stock rating boost from Raymond James Financial.
1 report, 1 independent
Updated Sat 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided average rating data for Quince Therapeutics, Inc., following a stock rating boost from Raymond James Financial.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Raymond James Financial
American Investment Bank and Financial Services Firm
- Mastercard extended digital payment access in Morocco and partnered with OpenAI, while Cantor Fitzgerald and Raymond James Financial updated ratings.
- Citigroup reiterated a market perform rating, Bank of America restated an underperform rating, and Raymond James Financial started coverage for Omega Healthcare Investors, Inc.
Related events
- MarketBeat reported an average stock rating for Superior Group of Companies.
- Spark I Acquisition Co. filed reports with the SEC and MarketBeat reported its average stock rating.
- MarketBeat reported average stock ratings while Jefferies Financial Group reiterated a buy rating for Sequoia Economic Infrastructure Inc.
- MarketBeat provided average stock rating data for Suburban Propane Partners on November 4, 2026.
- MarketBeat provided average rating data for Bluejay Diagnostics, Inc. on October 22, 2026.